FindTrial
Sign In

Diphenoxylate/Atropine

DRUG3 trials

Sponsors

University of California, San Francisco, National Cancer Institute (NCI), University of North Carolina, Chapel Hill

Conditions

Bowel Diseases, InflammatoryBreast AdenocarcinomaHER2-positive Breast CancerPouch, IlealPouches, IleoanalRecurrent Epithelial Cervical CarcinomaRecurrent Epithelial Endometrial CarcinomaRecurrent Platinum Resistant Epithelial Ovarian Carcinoma

Phase 2

Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
CompletedNCT03094052
University of California, San FranciscoHER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 +6
Start: 2018-10-09End: 2022-10-31Updated: 2025-06-26
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
TerminatedNCT06865677
National Cancer Institute (NCI)Recurrent Platinum Resistant Epithelial Ovarian Carcinoma, Recurrent Epithelial Endometrial Carcinoma, Recurrent Epithelial Cervical Carcinoma
Start: 2025-06-09End: 2025-07-01Updated: 2026-01-21

Phase 4

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
Not yet recruitingNCT07756359
University of North Carolina, Chapel HillPouch, Ileal, Pouches, Ileoanal, Bowel Diseases, Inflammatory
Start: 2026-09-01End: 2027-09-01Target: 20Updated: 2026-08-10